Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

June 2028 116

  1. Primary completion PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06445608

  2. Study completion Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06499857

  3. Primary completion RECOMMEND Platform Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06526533

  4. Primary completion Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06672159

  5. Study completion A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06789302

  6. Primary completion A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06789302

  7. Primary completion Safety of Short-course of NSAIDs in Pediatric Patients With CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06860711

  8. Study completion TECTONIC CAD IVL IDE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06885177

  9. Primary completion TaVNS for Acute Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06918964

  10. Study completion Study of Human Ocular Hemodynamics by Holography Dopple Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989996

  11. Primary completion Study of Human Ocular Hemodynamics by Holography Dopple Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989996

  12. Study completion CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06994975

  13. Study completion Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07021313

  14. Study completion Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07223593

  15. Primary completion Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07223593

  16. Study completion A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07239570

  17. Primary completion A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07239570

  18. Study completion Functional Improvement in Subacute/Chronic Stroke Through Non-invasive Virtual-reality-Based Telerehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07240948

  19. Primary completion Dronedarone Rhythm Intervention for Early Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07270848

  20. Primary completion TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07334691

  21. Primary completion Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07338175

  22. Study completion HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07402239

  23. Primary completion HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07402239

  24. Study completion T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07422831

  25. Primary completion Chocolate Balloon vs Standard Balloon Angioplasty Before Drug-Coated Balloon Treatment for Femoropopliteal Artery Narrowing or Blockage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471087

  26. Study completion Trial Phase: Syndemic Adapted Medly Uganda Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07525271

  27. Study completion Patient Quality of Recovery After TAVR With Different Sedation Regimens Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07556523

  28. Primary completion Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07654062

  29. Primary completion Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07740330

  30. Study completion Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07811934

  31. Study completion Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877519

  32. Primary completion Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877519

  33. Primary completion Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06453876

  34. Study completion A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06991257

  35. Primary completion A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07931495

  36. Study completion Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07295522

  37. Primary completion GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613437

  38. Study completion Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07566091

  39. Study completion A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06925750

  40. Primary completion A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06925750

  41. Study completion Prevent Cardiac Surgery Associated AKI Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06620523

  42. Primary completion Efficacy and Mechanism of Yanjiu Needle for Pharyngeal Dysphagia Based on sEMG Features Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07656025

  43. Study completion A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07595549

  44. Study completion Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687186

  45. Primary completion Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687186

  46. Study completion Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05987670

  47. Primary completion Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05987670

  48. Study completion Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06767345

  49. Study completion LVAD Conditioning for Cardiac Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03238690

  50. Primary completion LVAD Conditioning for Cardiac Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03238690

  51. Study completion Limiting AAA With Metformin (LIMIT) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04500756

  52. Primary completion Limiting AAA With Metformin (LIMIT) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04500756

  53. Primary completion Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05180773

  54. Study completion Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05283356

  55. Study completion Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05867381

  56. Primary completion Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05867381

  57. Study completion Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Drug-eluting Stent Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05955365

  58. Primary completion Nectero EAST System Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06001918

  59. Study completion Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06092736

  60. Study completion Evaluation of the InterFACE-AR System for Cardiopulmonary Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06411327

  61. Study completion Using AI Systems to Optimize the Clinical Outcome of Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06828679

  62. Study completion Efficacy and Safety Study of Isuzinaxib in Subjects With DKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06962098

  63. Primary completion Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07037433

  64. Primary completion Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07037459

  65. Study completion Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07141303

  66. Study completion A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07162597

  67. Study completion Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07244003

  68. Study completion CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07284199

  69. Primary completion LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07288398

  70. Study completion Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07296484

  71. Primary completion Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365475

  72. Study completion Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07562477

  73. Primary completion Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07616544

  74. Study completion Pro-urokinase for Extended-Window Posterior Circulation Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617870

  75. Primary completion HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07721584

  76. Study completion Ezetimibe for Arrhythmia Recurrence After AF Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752758

  77. Study completion Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Activities Following Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07759791

  78. Study completion Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07778823

  79. Study completion A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816198

  80. Primary completion A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816198

  81. Primary completion Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07846488

July 2028 92

  1. Study completion Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04818645

  2. Primary completion Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04818645

  3. Study completion Unloading in Heart Failure Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05064202

  4. Study completion Colchicine Use for Primary Prevention of Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05175274

  5. Study completion Folic Acid Supplementation in Calcific Aortic Valve Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05861648

  6. Study completion Effects of Pioglitazone in Calcific Aortic Valve Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05875675

  7. Study completion DCB for CAD With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07009938

  8. Study completion Safety and Efficacy of J147 in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07430917

  9. Study completion POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07469722

  10. Primary completion Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07476898

  11. Primary completion Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07682922

  12. Primary completion Apixaban Versus Warfarin for Left Ventricular Thrombus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07709780

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05211167

  2. Study completion A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05515393

  3. Primary completion A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05515393

  4. Study start Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05700266

  5. Study start Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05940220

  6. Study completion Using AR Dental Care Training on Periodontal Status, Blood Sugar Control and QoL in Patients With Type 2 Diabetes Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05993741

  7. Primary completion Using AR Dental Care Training on Periodontal Status, Blood Sugar Control and QoL in Patients With Type 2 Diabetes Registry record

    Expected 2023-12-30; that period ended on 2023-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05993741

  8. Study completion The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01845506

  9. Primary completion Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02022293

  10. Study completion Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02490306

  11. Primary completion Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02490306

  12. Primary completion TARGET BP I Clinical Trial Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02910414

  13. Study completion Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02988245

  14. Study completion Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03021928

  15. Primary completion Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03097107

  16. Study completion Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03186404

  17. Study completion Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03574311

  18. Study completion Screening for Cancer in Patients With Unprovoked VTE Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03937583

  19. Primary completion Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04083339

  20. Study completion The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04163835

  21. Study completion Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04277702

  22. Study completion Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04433533

  23. Study completion The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04455178

  24. Primary completion The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04455178

  25. Study completion Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04502017

  26. Primary completion Magnesium Treating Subarachnoid Hemorrhage Vasospasm Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04613960

  27. Primary completion Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04654507

  28. Study completion Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04664283

  29. Primary completion Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04664283

  30. Study completion GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04796428

  31. Primary completion GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04796428

  32. Study completion Natural History of COVID-19-Related Atrial Fibrillation Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04830774

  33. Study completion Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04874051

  34. Primary completion Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04874051

  35. Study completion Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04915365

  36. Study completion Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04929600

  37. Study completion Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04967573

  38. Primary completion Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04984954

  39. Study completion The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05005741

  40. Primary completion The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05005741

  41. Study completion Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05054842

  42. Primary completion Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05054842

  43. Study completion An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05089435

  44. Study completion The Effects of TMZ on Diabetic Nephropathy Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05147194

  45. Primary completion The Effects of TMZ on Diabetic Nephropathy Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05147194

  46. Study completion A Digital Solution for Patients With Heart Failure Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05193344

  47. Primary completion Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05212597

  48. Study completion Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05225077

  49. Study completion Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05263778

  50. Study completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05275296

  51. Primary completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05275296

  52. Study completion The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05350124

  53. Primary completion The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05350124

  54. Study completion NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05375110

  55. Study completion Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05389254

  56. Study completion The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF) Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05400928

  57. Primary completion A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05415995

  58. Study completion Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05423626

  59. Primary completion Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05423626

  60. Primary completion VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05443542

  61. Primary completion Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05500937

  62. Study completion Prediabetes Management Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05531838

  63. Primary completion Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05553093

  64. Study completion Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05554822

  65. Primary completion Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05554822

  66. Primary completion CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE) Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05578521

  67. Study completion Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05700097

  68. Study completion Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05836753

  69. Study completion A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05843162

  70. Primary completion A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05843162

  71. Primary completion A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05884502

  72. Study completion Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05927766

  73. Primary completion Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05927766

  74. Primary completion Evaluation of the Effectiveness and Safety of ABAStroke Registry record

    Expected 2023-12-31; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05979324

  75. Primary completion Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05988450

  76. Study start Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06129526

  77. Study start Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2023-12; that period ended on 2023-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06141980

  78. Study completion Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management. Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04725526

  79. Study completion PVP-Guided Decongestive Therapy in HF Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05217342

  80. Primary completion PVP-Guided Decongestive Therapy in HF Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05217342

  81. Study completion Echocardiography by Non-cardiologist in Early Management of Patients With Chest Pain Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05306730

  82. Study start Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide® Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06024525

  83. Study start Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06166524

  84. Study start Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS) Registry record

    Expected 2024-01-01; that period ended on 2024-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06177808

  85. Primary completion Fluoroscopy Reduction or Elimination in CIED Implants Registry record

    Expected 2024-01-03; that period ended on 2024-01-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04919733

  86. Study completion A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Registry record

    Expected 2024-01-04; that period ended on 2024-01-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05759897

  87. Study completion SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial Registry record

    Expected 2024-01-10; that period ended on 2024-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05159947

  88. Primary completion SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial Registry record

    Expected 2024-01-10; that period ended on 2024-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05159947

  89. Primary completion ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood Registry record

    Expected 2024-01-13; that period ended on 2024-01-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078943

  90. Study start Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Registry record

    Expected 2024-01-15; that period ended on 2024-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05702970

  91. Study completion Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion Registry record

    Expected 2024-01-21; that period ended on 2024-01-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03827915

  92. Primary completion Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion Registry record

    Expected 2024-01-21; that period ended on 2024-01-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03827915

  93. Study completion ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood Registry record

    Expected 2024-01-30; that period ended on 2024-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078943

  94. Study completion Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02022293

  95. Study completion A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03082508

  96. Study completion Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03097107

  97. Study completion Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke Registry record

    Expected 2024-01-31; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04419337

  98. Primary completion Empagliflozin and Atrial Fibrillation Treatment Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04583813

  99. Primary completion Evaluation of a Digital Care System in the Follow-Up Care of Atrial Fibrillation Patients Registry record

    Expected 2024-01-31; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05375877